Mike Lehmicke

Mike Lehmicke

Company: Alliance for Regenerative Medicine

Job title: Senior Vice President for Science & Industry Affairs

Seminars:

Chair’s Closing Remarks 6:00 pm

Read more

day: Conference Day One- pt 2

Panel Discussion: Navigating Global Regulatory Challenges in Cell & Gene Therapy 4:30 pm

• Diverging Regulatory Pathways: Understanding key differences in regulatory requirements between the FDA, EMA, and other global regulators in cell and gene therapy • Exploring ongoing initiatives for global regulatory convergence and the impact on innovation and patient access • Perspectives from regulators in the U.S., EU, Asia, and other countries on navigating local challenges…Read more

day: Conference Day One- pt 2

Navigating New Horizons: Gene Therapy Breakthroughs & Challenges in the Rare Disease Landscape 9:00 am

• What emerging innovations does 2025 hold for rare disease treatment? • What lessons have we learned from 2024 and how can we overcome these roadblocks in 2025 for gene therapy development? • Understanding strategic collaborations by leveraging partnerships for accelerated progressRead more

day: Conference Day One pt 1

Chair’s Opening Remarks 8:25 am

Read more

day: Conference Day One pt 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.